XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 9,707 $ 12,694
Short-term investments 680 498
Accounts receivable (net of allowance for doubtful accounts of $76 in 2023 and $72 in 2022) 10,415 9,450
Inventories (excludes inventories of $3,284 in 2023 and $2,938 in 2022 classified in Other assets - see Note 7) 5,863 5,911
Other current assets 6,737 7,169
Total current assets 33,402 35,722
Investments 1,290 1,015
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,256 in 2023 and $17,985 in 2022 21,758 21,422
Goodwill 21,209 21,204
Other Intangibles, Net 19,857 20,269
Other Assets 10,280 9,528
Total Assets 107,796 109,160
Current Liabilities    
Loans payable and current portion of long-term debt 2,672 1,946
Trade accounts payable 3,680 4,264
Accrued and other current liabilities 13,000 14,159
Income taxes payable 1,872 1,986
Dividends payable 1,907 1,884
Total current liabilities 23,131 24,239
Long-Term Debt 28,074 28,745
Deferred Income Taxes 1,442 1,795
Other Noncurrent Liabilities 8,244 8,323
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022 1,788 1,788
Other paid-in capital 44,467 44,379
Retained earnings 62,039 61,081
Accumulated other comprehensive loss (4,883) (4,768)
Stockholders' equity before deduction for treasury stock 103,411 102,480
Less treasury stock, at cost: 1,039,651,210 shares in 2023 and 1,039,269,638 shares in 2022 56,577 56,489
Total Merck & Co., Inc. stockholders’ equity 46,834 45,991
Noncontrolling Interests 71 67
Total equity 46,905 46,058
Liabilities and Equity $ 107,796 $ 109,160